AL
The startup develops a diagnostic blood test that utilizes a panel of specific blood biomarkers and a proprietary algorithm to identify individuals likely to have endometriosis. This technology enables healthcare professionals to achieve a more accurate diagnosis, leading to improved treatment options and enhanced quality of life for patients assigned female at birth.
Updated 3 months ago
Funding
$4.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a diagnostic blood test that utilizes a panel of specific blood biomarkers and a proprietary algorithm to identify individuals likely to have endometriosis. This technology enables healthcare professionals to achieve a more accurate diagnosis, leading to improved treatment options and enhanced quality of life for patients assigned female at birth.